RLYB CIK: 1739410

Rallybio Corp

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−45.5
FY22:
−57.3
FY23:
−60.3
FY24:
−49.3
FY25:
−29.8
Change from FY21 to FY25
millions USD
FY21:
−2.33
FY22:
−112
FY23:
27.7
FY24:
33.5
FY25:
47.3
Change from FY21 to FY25
millions USD
FY21:
83.0
FY22:
51.1
FY23:
0.14
FY24:
5.20
FY25:
0.02
millions USD
FY21:
–
FY22:
−118
FY23:
−32.5
FY24:
−10.6
FY25:
17.5
(positive)
Change from FY21 to FY24
millions USD
FY21:
−45.9
FY22:
−57.3
FY23:
−60.3
FY24:
−49.3
FY25:
–

All amounts in millions USD Data source:SEC EDGAR